Back to Treatments
Transplant & Hematology

Thalassemia Treatment

地中海贫血治疗

Duration

HSCT: 4-6 weeks inpatient; Medical management: lifelong

Recovery

HSCT: 3-6 months for immune recovery; transfusion independence achieved post-engraftment

$

Savings

~84% vs US

Price Comparison
China$20,000 - $60,000
$40,000
United States$100,000 - $400,000
$250,000
Save approximately 84%

Average savings compared to US prices

About This Treatment

Comprehensive thalassemia management including optimized transfusion therapy, iron chelation, and curative allogeneic hematopoietic stem cell transplantation. Southern China (Guangxi, Guangdong, Hainan) has the highest thalassemia prevalence globally, resulting in world-leading clinical expertise and transplant volumes. Gene therapy clinical trials using CRISPR-based approaches are also underway at select centers, offering potential future cures without donor dependency.

Procedure Steps
1

Disease Characterization & Iron Assessment

Hemoglobin electrophoresis, genetic mutation analysis, cardiac/liver MRI T2* for iron quantification, and ferritin trending

Duration: 3-5 days
2

Transplant Evaluation (curative intent)

Pesaro risk classification, donor search and HLA matching, organ function assessment, and iron reduction if needed

Duration: 1-2 weeks
3

Conditioning & Transplant

Myeloablative conditioning followed by matched sibling, unrelated, or haploidentical stem cell infusion

Duration: 4-6 weeks
4

Post-Transplant Monitoring

Engraftment confirmation, chimerism assessment, GVHD prophylaxis tapering, and iron overload management post-cure

Duration: 6-12 months
Benefits
  • World-leading thalassemia transplant experience in southern China
  • Cure rates exceeding 90% for low-risk patients with matched donors
  • CRISPR gene therapy trials available at select centers
  • Comprehensive iron overload management expertise
Considerations
  • HSCT carries graft rejection and GVHD risks
  • Pre-existing iron overload increases transplant complications
  • Gene therapy is still experimental with limited long-term data
  • Mixed chimerism may result in partial transfusion dependence

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.